Journal profile · Infectious Diseases
JAIDS Journal of Acquired Immune Deficiency Syndromes
ISSN 1525-4135 · eISSN 1077-9450 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Monthly · Founded 1999
JAIDS Journal of Acquired Immune Deficiency Syndromes: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.19; JCR Q3 (journal website); hybrid open access; median 145 days to acceptance (61 articles, last 24 months); community-reported acceptance: fairly hard; 229 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
JAIDS Journal of Acquired Immune Deficiency Syndromes is published by Lippincott Williams and Wilkins Ltd. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are HIV/AIDS Research and Interventions, HIV Research and Treatment and HIV/AIDS drug development and treatment, together about 56.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
JAIDS: Journal of Acquired Immune Deficiency Syndromes seeks to end the HIV epidemic by presenting important new science across all disciplines that advance our understanding of the biology, treatment and prevention of HIV infection worldwide. JAIDS: Journal of Acquired Immune Deficiency Syndromes is the trusted, interdisciplinary resource for HIV- and AIDS-related information with a strong focus on basic and translational science, clinical science, and epidemiology and prevention. Co-edited by the foremost leaders in clinical virology, molecular biology, and epidemiology, JAIDS publishes vital information on the advances in diagnosis and treatment of HIV infections, as well as the latest research in the development of therapeutics and vaccine approaches. This ground-breaking journal brings together rigorously peer-reviewed articles, reviews of current research, results of clinical trials, and epidemiologic reports from around the world.
Source: LetPub
Research area (LetPub): Infectious Diseases
Editor-in-chief Paul A. VolberdingPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- HIV/AIDS Research and InterventionsMedicine24.4%
- HIV Research and TreatmentImmunology and Microbiology18.3%
- HIV/AIDS drug development and treatmentMedicine13.7%
- HIV-related health complications and treatmentsMedicine10.1%
- HIV, Drug Use, Sexual RiskMedicine5.8%
- Adolescent Sexual and Reproductive HealthHealth Professions5.7%
- Pneumocystis jirovecii pneumonia detection and treatmentMedicine2.4%
- Sex work and related issuesSocial Sciences2.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Immunology | Zone 3 |
| Minor | Infectious Diseases | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Immunology | Zone 3 |
| Minor | Infectious Diseases | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Immunology | Zone 3 |
| Minor | Infectious Diseases | Zone 3 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q3 · IMMUNOLOGY · rank 135/183
- JCR Q3 · INFECTIOUS DISEASES · rank 87/141
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.19LetPub ·
- Impact factor (publisher)
- 2.3Publisher website ·
- CiteScore 2026-06
- 4LetPub ·
- SJR 2026-06
- 1.07LetPub ·
- SNIP 2026-06
- 0.91LetPub ·
- h-index
- 142LetPub ·
- h-index
- 193OpenAlex ·
- i10-index
- 6,504OpenAlex ·
- 2-year mean citedness
- 2.51OpenAlex ·
- Self-citation rate
- 4.3%LetPub ·
- Share of gold OA articles
- 24.18%LetPub ·
Volume
- Articles per year
- 213LetPub ·
Articles by year OpenAlex count · 11,157 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 154 | 74 | 16 |
| 2025 | 229 | 164 | 359 |
| 2024 | 240 | 186 | 1,187 |
| 2023 | 208 | 165 | 1,215 |
| 2022 | 251 | 201 | 2,636 |
| 2021 | 281 | 215 | 4,086 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
145 daysMedian, submission to acceptance · P25–P75 114 days – 212 days
- Acceptance to online
- —
- Submission to online
- —
- Sample
- 61 articles with submission and acceptance dates (501 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–6 weeksLetPub ·
- Average acceptance (community reports)
- Fairly hardLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1999
- ISSN
- 1525-4135
- Electronic ISSN
- 1077-9450
- Latest issue on the website
- Volume 101, Issue 10 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about JAIDS Journal of Acquired Immune Deficiency Syndromes
What CAS zone is JAIDS Journal of Acquired Immune Deficiency Syndromes in?
In the 2025 upgraded edition of the CAS Journal Ranking, JAIDS Journal of Acquired Immune Deficiency Syndromes is in Zone 3 of Medicine, and in Zone 3 of the minor category Immunology / Infectious Diseases. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JAIDS Journal of Acquired Immune Deficiency Syndromes?
The latest impact factor listed by LetPub is 2.19; CiteScore 4, h-index 193.
How long does peer review take at JAIDS Journal of Acquired Immune Deficiency Syndromes?
Based on the dates recorded on 61 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 145 days (interquartile range 114–212 days); authors report an average review time of 3–6 weeks; the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is JAIDS Journal of Acquired Immune Deficiency Syndromes in?
The journal's website gives JCR Q3; by category, IMMUNOLOGY Q3 (135/183), INFECTIOUS DISEASES Q3 (87/141). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 3 of Medicine.
Which databases index JAIDS Journal of Acquired Immune Deficiency Syndromes?
According to LetPub and DOAJ records, JAIDS Journal of Acquired Immune Deficiency Syndromes is indexed in SCIE and Scopus.
Is JAIDS Journal of Acquired Immune Deficiency Syndromes open access, and what is the APC?
JAIDS Journal of Acquired Immune Deficiency Syndromes is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .